-
-
Acute lower respiratory tract infection (bronchitis) is the most common complaint bringing patients to the doctor in England, where it is estimated that 75% of these patients receive an antibiotic at the first visit.
-
By Claire Henchcliffe, MD
Synopsis: Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinsons disease after some 6-12 months of treatment.
-
By Claire Henchcliffe, MD
Assistant Professor of the Department of Neurology at Weill Medical College, Cornell University
Dr. Henchcliffe is on the speakers bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim.
Synopsis: Depression and anxiety in Parkinsons disease might be associated with a specific loss of dopamine and noradrenaline innervation in the limbic system.
-
By M. Flint Beal, MD
Professor and Chairman of the Department of Neurology at Cornell Medical College
Dr. Beal reports no consultant, stockholder, speakers bureau, research, or other relationships related to this field of study.
-
By Michael Rubin, MD
Professor of Clinical Neurology at NewYork-Presbyterian Hospital, Cornell Campus
Dr. Rubin is on the speakers bureau for Athena Diagnostics and does research for Pfizer and Merck.
-
By Alan Z. Segal, MD
Assistant Professor, Department of Neurology, Weill Cornell Medical College, and Attending Neurologist at NewYork-Presbyterian Hospital
Dr. Segal is on the speakers bureau of Boehringer-Ingelheim.
Synopsis: There was an increased incidence of injection site reactions among vaccine treated patients, but no difference in the incidence of serious adverse events.
-
-
-